European Archives - Page 12 of 1163 - European Medical Journal

Hip Fracture Recovery in Older Women: Testosterone Falls Short

In the STEP-HI randomized trial, older women recovering from hip fracture saw no added benefit in mobility from combining exercise with testosterone therapy.

Indoor Triggers That Worsen Childhood Asthma

Discover a new study that has assessed the relationship between indoor home environmental exposures and lung function in children with asthma.

Targeted Liver Disease Screening Needed for Patients with Diabetes

The results suggest that while MASLD is common in patients with T2DM in primary care, advanced liver disease is rare.

EAN 2025: Blood Test for Insulin Resistance Predicts Cognitive Decline in Alzheimer’s

A routine blood test for insulin resistance can predict which Alzheimer’s patients are at risk of rapid cognitive decline.

Metabolic Syndrome Drives Degenerative Changes in Psoriatic Arthritis

A long-term PsA study shows metabolic syndrome is tied to degenerative spine changes, but not joint damage, offering new insight into managing comorbidities.

EAN 2025: Nocturnal Heart Rate Can Predict Stroke and Depression Years in Advance

Nighttime heart rate variability may reveal hidden risks for stroke, depression, and dementia, years before symptoms appear.

Longer Duration of Obesity Linked to Poorer Survival in Children with Leukaemia

Children with ALL who are overweight or obese at multiple points during treatment have worse survival rates and higher relapse risk, according to a cohort study of 794 patients.

Healthcare-Associated Infections Affect Over 50% of Care Home Residents

More than half of residents in European care homes experience at least one healthcare-associated infection each year, according to a major ECDC-led study.

Weight Loss Surgery Linked to Psoriasis Symptom Relief

Following surgery, 97.2% of patients experienced a reduction in psoriasis severity to mild levels or complete resolution.

New Evidence Supports Finerenone Use in Heart Failure, Regardless of Frailty

Finerenone benefits heart failure patients with preserved ejection fraction, regardless of frailty, supporting its wider clinical use.